Benchling for Vaccines R&D
Integrate reverse vaccinology approaches, discover novel adjuvants, and improve production yield.
Vaccines Research
-
Integrate reverse vaccinology approaches into vaccine antigen discovery.
-
Sequence whole genomes of biological target or pathogens
-
Express recombinant proteins with functional activity
-
Identify novel candidate antigens
-
-
Discover novel adjuvants.
-
Perform HTS and in-silico screening of new adjuvant candidates for vaccines
-
Characterize novel adjuvants for confirmatory activity
-
Optimize new adjuvants
-
-
Leverage systems biology and other computational methods to predict the safety and the efficacy of vaccines.
-
Centralize data on a single platform to analyze antigen and protective epitope sequences
-
Run structural biology experiments and workflows to redesign broadly protective antigens
-
Incorporate immunization results to improve computational methods
-
Vaccines Development
-
Accelerate vaccine production with synthetic technologies.
-
Design custom gene and protein constructs
-
Manage synthesis workflows for antigens and variants
-
Maximize vaccine production with high expression and improved capacity
-
-
Characterize and test adjuvants and immuno-potentiators.
-
Centralize incoming raw material characterization results
-
Integrate all results from intermediates, bulk material and other downstream testing
-
Build a comprehensive characterization profile of vaccine product
-
-
Continuously improve and modernize process.
-
Identify and define key process performance metrics
-
Integrate with production automation and monitor process continuously
-
Generate actionable evidence to improve process output
-
Join over 170,000 scientists using
Benchling to power life science R&D